Moleculin Biotech Inc. (MBRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.83
-0.08 (-4.19%)
At close: Jan 15, 2025, 3:59 PM
1.85
1.09%
After-hours Jan 15, 2025, 04:09 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 127.00K | 222.00K | 260.00K | 285.00K | 185.00K | 68.00K | 18.00K | 6.16K | n/a |
Gross Profit | -127.00K | -222.00K | -260.00K | -285.00K | -185.00K | -68.00K | -18.00K | -6.16K | n/a |
Operating Income | -29.63M | -30.64M | -22.97M | -19.74M | -17.52M | -15.03M | -8.65M | -3.88M | -738.23K |
Interest Income | 1.37M | 240.00K | 306.00K | 13.00K | 13.00K | n/a | n/a | n/a | 24.32K |
Pretax Income | -29.77M | -29.02M | -15.89M | -17.36M | -13.43M | -11.88M | -9.80M | -3.93M | -748.36K |
Net Income | -29.77M | -27.41M | -8.86M | -15.00M | -13.21M | -11.88M | -9.80M | -3.93M | -748.36K |
Selling & General & Admin | 10.02M | 11.67M | 8.39M | 6.79M | 6.31M | 5.30M | 4.09M | 2.38M | 477.81K |
Research & Development | 19.49M | 18.97M | 14.42M | 12.76M | 11.01M | 9.73M | 4.54M | 1.50M | 260.42K |
Other Expenses | 127.00K | 40.00K | 164.00K | 200.00K | 199.00K | -40.00K | 18.00K | 6.16K | n/a |
Operating Expenses | 29.63M | 30.64M | 22.97M | 19.74M | 17.52M | 15.03M | 8.65M | 3.88M | 738.23K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 43.21K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -668.93K |
Cost & Expenses | 29.63M | 30.64M | 22.97M | 19.74M | 17.52M | 15.03M | 8.65M | 3.88M | 738.23K |
Income Tax | n/a | -1.61M | -7.03M | -2.36M | -229.00K | 3.15M | 1.15M | n/a | -1.77M |
Shares Outstanding (Basic) | 1.98M | 1.91M | 1.79M | 656.38K | 452.46K | 287.82K | 206.32K | 109.19K | 63.00K |
Shares Outstanding (Diluted) | 1.98M | 1.91M | 1.79M | 656.38K | 452.46K | 287.82K | 206.32K | 109.19K | 63.24K |
EPS (Basic) | -15.07 | -14.37 | -4.94 | -22.85 | -29.18 | -41.26 | -47.52 | -35.96 | -11.88 |
EPS (Diluted) | -15.07 | -14.37 | -4.94 | -22.85 | -29.18 | -41.26 | -47.52 | -35.96 | -11.83 |
EBITDA | -29.50M | -30.51M | -22.80M | -19.54M | -13.25M | -14.96M | -8.63M | -3.88M | n/a |
Depreciation & Amortization | 127.00K | 222.00K | 260.00K | 285.00K | 185.00K | 68.00K | 18.00K | 6.16K | 1.77M |